Monday: March 25, 2019

Opening Lecture

HIV, STI, and HCV, Oh My!
Marty Soehnlen, PhD
Presentation

Conference Primer

Current Epidemiology of HIV in America
John Brooks, MD
Presentation

Overview of HIV Testing Practices and Technology
S. Michele Owen, PhD
Presentation

Hepatitis C Virus Diagnostic Methodologies
Saleem Kamili, PhD
Presentation

HIV is an STI—Let’s Not Forget the Other Curable STI that Play a Role in HIV Prevention & Control
Barbara Van der Pol, PhD
Presentation

Update from FDA on Reclassification of HCV and HIV Diagnostic Tests from Class III to Class II
Julia Lathrop, PhD
Presentation

Tuesday: March 26,2019

Session A: Implementation and Impact of the HIV Laboratory Algorithm in the US

Shared Service Success: Six Years of HIV Nucleic Acid Testing for US Public Health Laboratories
Anne Gaynor, PhD,
Presentation

Identifying Acute HIV Infection, National HIV Surveillance System
Laurie Linley, MPH
Presentation

Trends in Diagnosis of Acute HIV Infection, New York City, 2010-2017
Emily Westheimer, MS
Presentation

An Improved 4th Generation Prototype Assay for Earlier Detection of HIV Acute Infection
Xiaoxing Qiu, PhD
Presentation

Improved HIV Diagnostic Report Turnaround Time Using the HIV Algorithm Workflow System
Erin Goecker, MS
Presentation

Routine HIV Testing Results in 6 U.S. Clinical Laboratories Using the CDC/APHL Laboratory HIV Testing Algorithm with Geenius HIV 1/2 Supplemental Assay
Laura Wesolowski, PhD
Presentation

Session B: Updates on HIV-2 Testing in the US

Avioq VioOne HIV Profile Supplemental Assay for confirmation and differentiation of HIV-1 and HIV-2 antibodies
Michael Cronin, MS
Presentation

Differentiation between HIV-2 Single-Infection and HIV-1/-2 Dual- Infection by the Bio-Rad GeeniusTM HIV 1/2 Supplemental Assay
Ming Chang, PhD, MB(ASCP)
Presentation

An Evaluation of Qualitative HIV-2 RNA Referral Testing
Linda Styer, PhD
Presentation

Clinical HIV-2 Viral Load Testing of a Large Population of HIV-2 Infected Individuals
Linda Styer, PhD
Presentation

HIV-1/2 Differentiation in the U.S. HIV Laboratory Testing Algorithm: High Burden, Low Yield
Anne Peruski, PhD
Presentation

Discussion Panel: Strategies and Stories of Improved Partnerships Between Laboratory and Programs

Discussants:
Christopher Finch, BS
Nicolas Epie, PhD
Monica Parker, PhD
Kristie Schwarzkopf, BS
Presentation

Session C: Roles for Quantitative and Qualitative Nucleic Acid Tests in Diagnostic Algorithms (Part 1)

Performance evaluation of a point-of-care whole blood viral load test (SAMBA II HIV-1 Semi-Q Whole Blood) to optimize HIV treatment
Gary Brook, MD FRCP DTM&H

Cross-clade HIV-1 DNA detection from frozen whole blood using droplet digital PCR
Erin Goecker, MS
Presentation

Determinants of DNA PCR uptake among HIV exposed infants attending clinic within a HIV program in Kenya; A retrospective cohort study
Douglas Gaitho, M.B.Ch.B
Presentation

Performance Characteristics of GeneXpert and Alere Q Point of Care Technologies for HIV Early Infant Diagnosis in Kenya
Dorcus Abuya, MSc
Presentation

Session D: Roles for Quantitative and Qualitative Nucleic Acid Tests in Diagnostic Algorithms (Part 2)

Performance of an Alternative HIV Diagnostic Algorithm Including HIV-1 RNA Viral Load Compared to the CDC/APHL Laboratory Diagnostic Algorithm
Marc Pitasi, MPH
Presentation

Could HIV-1 RNA be an Option as the Second Step in the HIV Diagnostic Algorithm?
Silvina Masciotra, MSc
Presentation

Evaluation of Contamination Risk during Processing by the cobas® e 602 Serology Module Prior to HIV/HCV Viral Load Testing on the cobas® 6800 System
Pedro Rodriguez, PhD
Presentation

SAMBA: A Point-of-Care NAT for Detection of HIV Viremia
Lauren Violette, MPH

Discussion Panel: Opportunities Created by Diagnostic HCV and HIV NAT

Discussants:
Ann Winters, MD
Ana María Cárdenas, Ph.D., D(ABMM)
Joanne Stekler, MD, MPH
Presentation

WEDNESDAY, MARCH 27 2019

Session E: Integrated Testing for Multiple Pathogens

A Newer Generation of Rapid Assays: Detection of HIV and Syphilis Simultaneously
Niel Constantine, PhD

Side by Side Comparison: DPP HIV Syphilis Assay System vs. Syphilis Health Check
Eugene Martin, PhD

Enhancing the Routine Screening Infrastructure to Address a Syphilis Epidemic in Miami-Dade County
Alejandro Larios

North Carolina Test, Link, Cure: Collaborating to Address Hepatitis C in At-Risk Populations
Rebecca Pelc, PhD

Discussion Panel: Integrated Testing and Screening—From Primary Care to Public Health

Discussants:
Vaneet Arora, MD
Lesley Miller, MD
Liisa Randall, PhD
Presentation

Session F: Novel Testing Strategies for STI and HCV

The Use of a Syphilis Rapid Test with Specimens from an HIV Cluster Investigation in rural West Virginia
Lara Pereira, PhD
Presentation

Performance of the Reverse Algorithm Using the Abbott Architect Syphilis TP and its Role in a “Blended” Diagnostic Application in Florida’s Public Health Testing Population
Yolanda Totten, BS, MT (AAB)
Presentation

Evaluation of the Point-of-Care SAMBA II HCV Qualitative Whole Blood Test
Sonny Michael Assennato, MSc

Session G: Testing Outside the Laboratory

Rapid Testing Algorithm Performance in a Low Prevalence Environment
Eugene Martin, PhD
Presentation

Failure of the Alere Determine 4th Generation Point of Care Test to Detect an Acute HIV-1 Infection
Carol Loring, MS
Presentation

Evaluation of Different Rapid Testing Algorithms for Venue-based Anonymous HIV Testing among Men Who Have Sex with Men (MSM), National HIV Behavioral Surveillance (NHBS), 2017
Shamaya Whitby, MS
Presentation

Quickie in the Club—You Are 7 Minutes from Your Status
Jonathon Antle
Presentation

Performance, Usability and Acceptance of the Blood-Based INSTI HIV Self-Test in High and low HIV Prevalent Populations
Rick Galli, BSc
Presentation

Implementation Challenges of App-Requested HIV and STI Home Test Kits Among Men Who Have Sex with Men
Ryan Zahn, MSPH
Presentation

Discussion Panel: Self-Testing and Self-Collection for HIV and STIs

Discussants:
Charlotte Gaydos, DrPH
Benjamin Tsoi, MD, MPH
Pollyanna Ch´avez, PhD
Presentation

THURSDAY, MARCH 28 2019

Session H: Expanding Access to Testing Through the Use of Dried Blood Spots

The Feasibility of Modified HIV and Antiretroviral Drug Testing Using Self-collected Dried Blood Spots from Men Who Have Sex with Men
Wei Luo, MS
Presentation

Comparison of the Geenius™ HIV-1/2 Supplemental Assay and HIV-1 Western Blot for HIV Rapid Test Confirmation from Dried Blood Spots
Tim Sullivan, BS
Presentation

Quantification of HIV-1 RNA in Dried Blood Spots (DBS) Using the Abbott RealTime HIV-1 DBS assay
Ming Chang, PhD, MB(ASCP)

Empowerment of Canada’s Indigenous Communities to Improve Access to HIV and HCV Testing using Dried Blood Spots
John Kim
Presentation

Session I: Emerging Testing Issues

Multiplex Screening Kit for Routine Monitoring of HIV Suppression and Drug Resistance
Jonathan Lipscomb, MPH
Presentation

Implementation of Next Generation Sequencing Technology for HIV Resistance Determination and Genotyping
Marie-Claire Rowlinson, PhD
Presentation

Independent assessment of the Sedia Asanté™ HIV-1 Rapid Recency® Assay
Eduard Grebe, PhD
Presentation

Performance of HIV Ag/Ab Assays on Samples from Individuals Initiating Antiretroviral Therapy During Acute HIV Infection
Mark Manak, PhD
Presentation

Case Study of the Value of Historical Archives for Diagnostic Advancements
Gary Murphy, PhD
Presentation